Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Keywords
(3)
Hiv Infection
Protease Inhibitor
Therapeutic Drug Monitoring
Subscribe
Academic
Publications
Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen - ANRS 111 trial
Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen - ANRS 111 trial,10.1111/j.
Edit
Benefit of therapeutic drug monitoring of protease inhibitors in HIV-infected patients depends on PI used in HAART regimen - ANRS 111 trial
(
Citations: 3
)
BibTex
|
RIS
|
RefWorks
Download
Xavier Duval
,
Elisabeth Rey
,
Solange Auleley
,
Gilles Peytavin
,
Michel Biour
,
Annie Métro
,
Cecile Goujard
,
Anne-Marie Taburet
,
Cecile Lascoux
,
Xaviere Panhard
,
Jean-Marc Tréluyer
,
Dominique Salmon-Céron
Journal:
Fundamental & Clinical Pharmacology - FUNDAM CLIN PHARMACOL
, vol. 23, no. 4, pp. 491-500, 2009
DOI:
10.1111/j.1472-8206.2009.00693.x
Cumulative
Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
(
blackwell-synergy.com
)
Citation Context
(1)
...The COPHAR 2–ANRS 111 trial is a multicentre, non-comparative pilot trial of early therapeutic drugmonitoring in HIV-positive patients naive for PI-containing HAART [
19
]...
Julie Bertrand
,
et al.
Influence of pharmacogenetics on indinavir disposition and short-term ...
References
(18)
Efficacy and safety of twice daily first-line ritonavir/indinavir plus double nucleoside combination therapy in HIV-infected individuals
(
Citations: 17
)
Frank Bergmann
,
Werner Wiesel
,
Ansgar Rieke
,
Albert Theisen
,
Mark Oette
,
Horst Carls
,
Stefan Fenske
,
Mathias Nadler
,
Heribert Knechten
Journal:
Aids
, vol. 14, no. 9, pp. 1181-1185, 2000
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV1 infection: 48-week results
(
Citations: 99
)
Robert L. Murphy
,
Scott Brun
,
Charles Hicks
,
Joseph J. Eron
,
Roy Gulick
,
Martin King
,
A. Clinton White
,
Constance Benson
,
Melanie Thompson
,
Harold A. Kessler
,
Scott Hammer
,
Richard Bertz
http://academic.research.microsoft.com/io.ashx?type=5&id=5806949&selfId1=0&selfId2=0&maxNumber=12&query=
Journal:
Aids
, vol. 15, no. 1, pp. F1-F9, 2001
Pharmacological Basis for Concentration-Controlled Therapy with Zidovudine, Lamivudine, and Indinavir
(
Citations: 32
)
THOMAS N. KAKUDA
,
LINDA M. PAGE
,
PETER L. ANDERSON
,
KEITH HENRY
,
TIMOTHY W. SCHACKER
,
FRANK S. RHAME
,
EDWARD P. ACOSTA
,
RICHARD C. BRUNDAGE
,
COURTNEY V. FLETCHER
Journal:
Antimicrobial Agents and Chemotherapy - ANTIMICROB AGENTS CHEMOTHER
, vol. 45, no. 1, pp. 236-242, 2001
Marked Intraindividual Variability in Antiretroviral Concentrations May Limit the Utility of Therapeutic Drug Monitoring
(
Citations: 36
)
Richard E. Nettles
,
Tara L. Kieffer
,
Teresa Parsons
,
James Johnson
,
Joel E. Gallant
,
Kathryn A. Carson
,
Robert F. Siliciano
,
Charles Flexner
Journal:
Clinical Infectious Diseases - CLIN INFECT DIS
, vol. 42, no. 8, pp. 1189-1196, 2006
A Randomized Controlled Trial of Therapeutic Drug Monitoring in Treatment-Naive and Experienced HIV1Infected Patients
(
Citations: 15
)
Brookie M Best
,
Miguel Goicoechea
,
Mallory D Witt
,
Loren Miller
,
Eric S Daar
,
Catherine Diamond
,
Jeremiah G Tilles
,
Carol A Kemper
,
Robert Larsen
,
Diane T Holland
,
Shelly Sun
,
Sonia Jain
http://academic.research.microsoft.com/io.ashx?type=5&id=37685850&selfId1=0&selfId2=0&maxNumber=12&query=
Journal:
Jaids-journal of Acquired Immune Deficiency Syndromes - JAIDS
, vol. 46, no. 4, pp. 433-442, 2007
Sort by:
Citations
(3)
Maximum Likelihood Estimation of Long-Term HIV Dynamic Models and Antiviral Response
Marc Lavielle
,
Adeline Samson
,
Ana Karina Fermin
Journal:
Biometrics
, pp. no-no, 2010
Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART
(
Citations: 3
)
Julie Bertrand
,
Jean-Marc Treluyer
,
Xavière Panhard
,
Agnes Tran
,
Solange Auleley
,
Elisabeth Rey
,
Dominique Salmon-Céron
,
Xavier Duval
Journal:
European Journal of Clinical Pharmacology - EUR J CLIN PHARMACOL
, vol. 65, no. 7, pp. 667-678, 2009
Place du test de permutation dans les modeles non lineairesa effets mixtes : application en pharmacogenetique
Julie Bertrand
,
Emmanuelle Comets
,
Celine M. Laffont
,
Marylore Chenel